Every year, millions of people get diagnosed with cancer, with each case requiring a unique approach to treatment. Physicians, however, often find it challenging to deliver personalized care due to a lack of access to relevant, patient-specific data. Currently, the bulk of prognostic evidence and treatment decisions in oncology rely on clinical trials, which typically omit this crucial patient-specific information. This leads to disparities in survival rates between clinical trial participants and patients observed in real-world settings. Our client saw this problem and set out to create a solution: an AI-powered clinical decision support system for personalizing cancer treatments, enriched with a decade's worth of patient-reported outcomes. To bring their vision to life, they sought the expertise of a top-tier AI development team. That's when they chose ITRex.
Tell us about your challenges, and we’ll come up with a viable solution!
